KURA ONCOLOGY, INC. (KURA) Free cash flow 2020–2025
KURA ONCOLOGY, INC. (KURA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$70.7MFY2025 · since FY2020: -$72.0M → -$70.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$70.7M | -152.8% |
| FY2024 | $133.8M | +207.1% |
| FY2023 | -$125.0M | -12.9% |
| FY2022 | -$110.7M | -4.7% |
| FY2021 | -$105.7M | -46.8% |
| FY2020 | -$72.0M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice